Ginny Devonshire

1.6k total citations
16 papers, 380 citations indexed

About

Ginny Devonshire is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ginny Devonshire has authored 16 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ginny Devonshire's work include Esophageal Cancer Research and Treatment (11 papers), Cancer Genomics and Diagnostics (5 papers) and Gastric Cancer Management and Outcomes (4 papers). Ginny Devonshire is often cited by papers focused on Esophageal Cancer Research and Treatment (11 papers), Cancer Genomics and Diagnostics (5 papers) and Gastric Cancer Management and Outcomes (4 papers). Ginny Devonshire collaborates with scholars based in United Kingdom, United States and Poland. Ginny Devonshire's co-authors include Rebecca C. Fitzgerald, Sriganesh Jammula, E. Ococks, Nicola Grehan, Alexander M. Frankell, Simon Tavaré, Shona MacRae, Xiaodun Li, Matthew Eldridge and Juliane Perner and has published in prestigious journals such as Science, Nature Communications and Nature Genetics.

In The Last Decade

Ginny Devonshire

16 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ginny Devonshire United Kingdom 8 193 142 130 124 120 16 380
Xin‐Gan Qin China 11 84 0.4× 114 0.8× 96 0.7× 139 1.1× 69 0.6× 25 316
Kyoung-Mee Kim South Korea 11 75 0.4× 174 1.2× 186 1.4× 99 0.8× 106 0.9× 14 376
Aafke Creemers Netherlands 11 125 0.6× 140 1.0× 215 1.7× 77 0.6× 121 1.0× 16 353
Bianca Grosser Germany 13 81 0.4× 123 0.9× 155 1.2× 75 0.6× 119 1.0× 35 352
Stefan Paul Moenig Germany 9 88 0.5× 102 0.7× 143 1.1× 90 0.7× 64 0.5× 21 300
Alexander M. Frankell United Kingdom 6 85 0.4× 84 0.6× 85 0.7× 64 0.5× 109 0.9× 7 221
Binyi Xiao China 13 103 0.5× 70 0.5× 226 1.7× 125 1.0× 82 0.7× 37 391
Keiji Nishibeppu Japan 10 76 0.4× 122 0.9× 94 0.7× 224 1.8× 186 1.6× 51 424
S.T. Kim South Korea 9 98 0.5× 210 1.5× 281 2.2× 110 0.9× 36 0.3× 20 403
Zhongli Zhan China 11 56 0.3× 223 1.6× 178 1.4× 78 0.6× 58 0.5× 23 361

Countries citing papers authored by Ginny Devonshire

Since Specialization
Citations

This map shows the geographic impact of Ginny Devonshire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ginny Devonshire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ginny Devonshire more than expected).

Fields of papers citing papers by Ginny Devonshire

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ginny Devonshire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ginny Devonshire. The network helps show where Ginny Devonshire may publish in the future.

Co-authorship network of co-authors of Ginny Devonshire

This figure shows the co-authorship network connecting the top 25 collaborators of Ginny Devonshire. A scholar is included among the top collaborators of Ginny Devonshire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ginny Devonshire. Ginny Devonshire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Devonshire, Ginny, Ahmad Miremadi, Liang Zhuang, et al.. (2023). SO-12 CLDN18.2 expression in resectable gastroesophageal cancers: Associated clinical and molecular signatures and impact of neoadjuvant chemotherapy on intratumor heterogeneity. Annals of Oncology. 34. S166–S167. 1 indexed citations
2.
Nowicki-Osuch, Karol, Lizhe Zhuang, Tik Shing Cheung, et al.. (2023). Single-Cell RNA Sequencing Unifies Developmental Programs of Esophageal and Gastric Intestinal Metaplasia. Cancer Discovery. 13(6). 1346–1363. 32 indexed citations
3.
4.
Foley, Kieran, David Shorthouse, Eric P. Rahrmann, et al.. (2023). SMAD4 and KCNQ3 alterations are associated with lymph node metastases in oesophageal adenocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(1). 166867–166867. 1 indexed citations
5.
Shorthouse, David, Lizhe Zhuang, Eric P. Rahrmann, et al.. (2023). KCNQ potassium channels modulate Wnt activity in gastro-oesophageal adenocarcinomas. Life Science Alliance. 6(12). e202302124–e202302124. 4 indexed citations
6.
Katz‐Summercorn, Annalise, Sriganesh Jammula, Anna Frangou, et al.. (2022). Multi-omic cross-sectional cohort study of pre-malignant Barrett’s esophagus reveals early structural variation and retrotransposon activity. Nature Communications. 13(1). 1407–1407. 11 indexed citations
7.
Nowicki-Osuch, Karol, Lizhe Zhuang, Sriganesh Jammula, et al.. (2021). Molecular phenotyping reveals the identity of Barrett’s esophagus and its malignant transition. Science. 373(6556). 760–767. 92 indexed citations
8.
McKenna, Sharon L., Darshan S. Chandrashekar, Alvin Wei Tian Ng, et al.. (2021). Alterations in the Ca2+ toolkit in oesophageal adenocarcinoma. SHILAP Revista de lepidopterología. 2(6). 543–575. 3 indexed citations
9.
Ococks, E., Alexander M. Frankell, Nicola Grehan, et al.. (2021). Longitudinal tracking of 97 esophageal adenocarcinomas using liquid biopsy sampling. Annals of Oncology. 32(4). 522–532. 66 indexed citations
10.
Li, Xiaodun, Sriganesh Jammula, Ginny Devonshire, et al.. (2021). Evidence that polyploidy in esophageal adenocarcinoma originates from mitotic slippage caused by defective chromosome attachments. Cell Death and Differentiation. 28(7). 2179–2193. 9 indexed citations
11.
Secrier, Maria, Jane Whitney Gibson, Robert Walker, et al.. (2021). Genomic Analysis of Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma. Cancers. 13(14). 3394–3394. 5 indexed citations
12.
Perner, Juliane, Sujath Abbas, Karol Nowicki-Osuch, et al.. (2020). The mutREAD method detects mutational signatures from low quantities of cancer DNA. Nature Communications. 11(1). 3166–3166. 6 indexed citations
13.
Devonshire, Ginny, Robert Walker, Matthew G. Lloyd, et al.. (2020). 474 GENOMIC ANALYSIS OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA. Diseases of the Esophagus. 33(Supplement_1). 2 indexed citations
14.
Bornschein, Jan, Lorenz Wernisch, Maria Secrier, et al.. (2019). Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction. International Journal of Cancer. 145(12). 3389–3401. 14 indexed citations
15.
Frankell, Alexander M., Sriganesh Jammula, Xiaodun Li, et al.. (2019). The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic. Nature Genetics. 51(3). 506–516. 124 indexed citations
16.
Li, Xiaodun, Hayley E. Francies, Ahmad Miremadi, et al.. (2019). Su2042 – Derivation of Oesophageal Organoids to Recapitulate the Heterogeneity of Primary Tumours and Provide a Model System for Precision Therapeutics. Gastroenterology. 156(6). S–696. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026